Melmar-T

Melanoma Margins Trial (MelMarT): A Phase III, multi centre, multi national randomised control trial investigating 1cm v 2cm wide excision margins for primary cutaneous melanoma
Description: This is a surgical trial comparing 2 different surgeries for patients with primary cutaneous melanoma- a 1cm excision margin v a 2cm wide excision margin
Study Phase: Phase 3
Principal Investigator: Ms Marlese Dempsey
Further information

Enquire about a Cancer Clinical Trial

If you would like more information on Cancer Clinical Trials you can contact us.